medigraphic.com
ISSN 1561-302X (Impreso)

2021, Número 3

<< Anterior Siguiente >>

Rev cubana med 2021; 60 (3)


Complicaciones y comorbilidades más frecuentes en la anemia drepanocítica

Soler NG

Idioma: Español
Referencias bibliográficas: 94
Paginas: 1-19
Archivo PDF: 391.38 Kb.


RESUMEN

Introducción: La anemia drepanocítica es una enfermedad pleiotrópica sistémica. Con su padecimiento, casi todos los órganos se afectan. Las formas de presentación de esta enfermedad varían entre los pacientes.
Objetivo: Describir las características principales de las complicaciones y comorbilidades más frecuentes en la anemia drepanocítica.
Método: Se realizó una revisión de la literatura, de artículos publicados en los últimos 10 años sobre complicaciones y comorbilidades más frecuentes en la anemia drepanocítica.
Conclusión: El conocimiento y diferenciación de las complicaciones y comorbilidades en la anemia drepanocítica permite administrar las terapias adecuadas.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Kato GJ, Piel FB, Reid CD, Gaston MH, Ohene-Frempong K, Krishnamurti L, et al. Sickle cell disease. Nature Reviews Disease Primers. 2018;4:18010.

  2. Chakravorty S, Williams TN. Sickle cell disease: a neglected chronic disease of increasing global health importance. Arch Dis Child. 2015;100:48-53. Disponible en: https://doi.org/10.1136/archdischild-2013-303773

  3. Badawy SM, Cronin RM, Hankins J, Crosby L, DeBaun M, Thompson AA, et al. Patient-centered-health interventions for children, adolescents, and adults with sickle cell disease: systematic review. Journal of Medical Internet Research. 2018;20(7):e10940. Disponible en: https://doi.org/10.2196/10940

  4. Dixit R, Nettem S, Madan SS, Soe HHK, Abas AB, Vance LD, et al. Folate supplementation in people with sickle cell disease. The Cochrane Database of Systematic Reviews. 2016;2:CD011130. Disponible en: https://doi.org/10.1002/14651858.CD011130.pub2

  5. TomlinsonWJ. Abdominal crises in sickle cell anemia: A clinicopathological study of eleven cases with a suggested explanation of their cause. Am J Med Sci. 1945;209:722-41.

  6. Ben Khaled M, Ouederni M, Mankai Y, Rekaya S, Ben Fraj I, Dhouib N, et al. Prevalence and predictive factors of splenic sequestration crisis among 423 pediatric patients with sickle cell disease in Tunisia. Blood Cells Mol Dis. 2020;80:102374.

  7. Saad AA, Beshlawi I, Al-Rawas AH, Zachariah M, Nazir HF, Wali Y. Human parvovirus B19 in children with sickle cell disease; poking the spleen. Oman Medical Journal. 2017;32(5):425-8. Disponible en: https://doi.org/10.5001/omj.2017.79

  8. Niss O, Fleck R, Makue F, Alsaied T, Desai P. Association between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemia. Blood. 2017;130:205-13.

  9. Aujla A, Dutta D, Amar S, Frishman W, Lim SH. Cardiovascular Sequelae of Sickle Cell Disease. Cardiol Rev. 2020;28:10-13. Disponible en: https://doi.org/10.1097/CRD.0000000000000264

  10. Powers W, Rabinstein A, Ackerson T. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018;49:e46-e110.

  11. Farooq S, Testai FD. Neurologic complications of sickle cell disease. Curr Neurol Neurosci Rep. 2019;19(4):17.

  12. Kwiatkowski JL, Kanter J, Fullerton HJ, Voeks J, Debenham E, Brown DG, et al. Ischemic Stroke in Children and Young Adults with Sickle Cell Disease (SCD) in the Post-STOP Era. Blood. 2015[acceso: 16/08/2020];126(23):68. Disponible en: Disponible en: http://www.bloodjournal.org/content/126/23/68

  13. Mishra SS, Senapati SB, Gouda AK, Behera SK, Patnaik A. Spontaneous extradural and subgaleal hematoma: A rare neurosurgical crisis of sickle cell disease. Asian Journal of Neurosurgery. 2017;12(1):47-50. Disponible en: https://doi.org/10.4103/1793-5482.144177

  14. Calvet D, Tuilier T, Mele N, Turc G, Habibi A. Low fetal hemoglobin percentage is associated with silent brain lesions in adults with homozygous sickle cell disease. Blood Adv. 2017;1:2503-9.

  15. Gilyard SN, Hamlin SL, Johnson J, Herr KD. Imaging review of sickle cell disease for the emergency radiologist. Emerg Radiol. 2020. Disponible en: https://doi.org/10.1007/s10140-020-01828-8

  16. Watchmaker JM, Juttukonda MR, Davis LT, Scott AO, Faraco CC, Gindville MC, et al. Hemodynamic mechanisms underlying elevated oxygen extraction fraction (OEF) in moyamoya and sickle cell anemia patients. Journal of Cerebral Blood Flow & Metabolism. 2018;38(9):1618-30. Disponible en: https://doi.org/10.1177/0271678X16682509

  17. Kassim AA, Pruthi S, Day M, Rodeghier M, Gindville MC. Silent cerebral infarcts and cerebral aneurysms are prevalent in adults with sickle cell anemia. Blood. 2016;127:2038-40.

  18. Newman S, Boulter JH, Malcolm JG, Pradilla I, Pradilla G. Outcomes in patients with moyamoya syndrome and sickle cell disease: a systematic review. World Neurosurg. 2020;135:165-70.

  19. Jordan LC, Kassim AA, Donahue MJ, Juttukonda MR, Pruthi S, Davis LT, et al. Silent infarct is a risk factor for infarct recurrence in adults with sickle cell anemia. Neurology. 2018;91(8):e781-e784. Disponible en: https://doi.org/10.1212/WNL.0000000000006047

  20. Albers GW, Caplan LR, Easton JD. Transient ischemic attack-proposal for a new definition. N Engl J Med. 2002;347:1713-16.

  21. Mack A, Thompson A. Primary and Secondary stroke prevention in children with sickle cell disease. J Pediatr Health Care. 2017;31:145-54.

  22. Kawadler JM, Clark CA, McKinstry RC, Kirkham FJ. Brain atrophy in paediatric sickle cell anaemia: findings from the silent infarct transfusion (SIT) trial. Br. J. Haematol. 2017;177:151-3.

  23. Wang MX, Pepin EW, Verma N, Mohammed TL. Manifestations of sickle cell disease on thoracic imaging. Clin Imaging. 2018;48:1-6.

  24. Novelli EM, Gladwin MT. Crises in Sickle Cell Disease. Chest. 2016;149(4):1082-93. Disponible en: https://doi.org/10.1016/j.chest.2015.12.016

  25. Mehrad B, Burdick MD, Wandersee NJ, Shahir KS, Zhang L. Circulating fibrocytes as biomarkers of impaired lung function in adults with sickle cell disease. Blood Adv. 2017;1:2217-24.

  26. Swift CA, Nance JW, Collins H, Ravenel JG. Incidence of pulmonary embolism in sickle cell anemia patients undergoing computed tomography pulmonary angiography in the emergency department. Journal of Thoracic Imaging. 2019;34(5):125-6.

  27. Bennewitz MF, Jimenez MA, Vats R, Tutuncuoglu E, Jonassaint J, Kato GJ, et al. Lung vaso-occlusion in sickle cell disease mediated by arteriolar neutrophil-platelet microemboli. JCI Insight. 2017;2(1):e89761.

  28. Anea CB. Pulmonary platelet thrombi and vascular pathology in acute chest syndrome in patients with sickle cell disease. Am J Hematol. 2016;91(2):173-8.

  29. Sparkenbaugh E, Pawlinski R. Prothrombotic aspects of sickle cell disease. J Thromb Haemost. 2017;15:1307-16.

  30. Jain S, Bakshi N, Krishnamurti L. Acute chest syndrome in children with sickle cell disease. Pediatr Allergy Immunol Pulmonol. 2017;30:191-201. Disponible en: https://doi.org/10.1089/ped.2017.0814

  31. Mehari A, Klings ES. Chronic pulmonary complications of sickle cell disease. Chest. 2016;149(5):1313-24. Disponible en: https://doi.org/10.1016/j.chest.2015.11.01

  32. Lovett PB, Sule HP, Lopez BL. Sickle cell disease in the emergency department. Hematol Oncol Clin North Am. 2017;31(6):1061-79.

  33. Mehari A, Igbineweka N, Allen D. Abnormal ventilation-perfusion scan is associated with pulmonary hypertension in sickle cell adults. J Nucl Med. 2019;60:86-92.

  34. Maron BA, Brittain EL, Choudhary G, Gladwin MT. Redefining pulmonary hypertension. Lancet Respir Med. 2018;6:168-70.

  35. Maron BA, Wertheim BM, Gladwin MT. Under pressure to clarify pulmonary hypertension clinical risk. Am J Respir Crit Care Med. 2018;197:423-6.

  36. Klings ES, Machado RF, Barst RJ, Morris CR, Mubarak KK. An official american thoracic society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease. Am J Respirrit Care Med. 2014;189:727-40.

  37. Mburu J, Odame I. Sickle cell disease: Reducing the global disease burden. Int J Lab Hematol. 2019;41(S1):82-8. Disponible en: https://doi.org/10.1111/ijlh.13023

  38. Cannas G, Merazga S, Virot E. Sickle cell disease and infections in high- and low-income countries. Mediterr J Hematol Infect Dis. 2019;11:e2019042. Disponible en: https://doi.org/10.4084/mjhid.2019.042

  39. Shinde S, Bakshi AP, Shrikhande AV. Infections in sickle cell disease. IAIM. 2015;2(11):26-34.

  40. Brown B, Dada-Adegbola H, Trippe C, Olopade O. Prevalence and etiology of bacteremia in febrile children with sickle cell disease at a Nigeria tertiary hospital. Mediterr J Hematol Infect Dis. 2017;9:e2017039. Disponible en: https://doi.org/10.4084/mjhid.2017.039

  41. Battersby AJ, Knox-Macaulay HH, Carrol ED. Susceptibility to invasive bacterial infections in children with sickle cell disease. Pediatric Blood & Cancer. 2010;55(3):401-6. Disponible en: https://doi.org/10.1002/pbc.22461

  42. Santoro JD, Myers L, Kanter J. Assessing the immunogenic response of a single center's pneumococcal vaccination protocol in sickle cell disease. J Pediatr Hematol Oncol. 2016;38:e102-6. Disponible en: https://doi.org/10.1097/MPH.0000000000000510

  43. Sobota A, Sabharwal V, Fonebi G, Steinberg M. How we prevent and manage infection in sickle cell disease. Br J Haematol. 2015;170:757-67. https://doi.org/10.1111/bjh.13526

  44. Bansil NH, Kim TY, Tieu L, Barcega B. Incidence of serious bacterial infections in febrile children with sickle cell disease. Clin Pediatr. 2013;52:661-6. Disponible en: https://doi.org/10.1177/0009922813488645

  45. Sadreameli SC, Reller ME, Bundy DG, Casella JF, Strouse JJ. Respiratory syncytial virus and seasonal influenza cause similar illnesses in children with sickle cell disease. Pediatr Blood Cancer. 2014;61:875-8. Disponible en: https://doi.org/10.1002/pbc.24887

  46. Rocha LC, Carvalho MOS, Nascimento VML, dos Santos MS, Barros TF, Adorno EV, et al. Nasopharyngeal and oropharyngeal colonization by staphylococcus aureus and streptococcus pneumoniae and prognostic markers in children with sickle cell disease from the northeast of brazil. Front Microbiol. 2017;8:217. Disponible en: https://doi.org/10.3389/fmicb.2017.00217

  47. Colston J, Atkins B. Bone and joint infection. Clin Med. 2018;18:150-4. Disponible en: https://doi.org/10.7861/clinmedicine.18-2-150

  48. Shah R, Taborda C, Chawla S. Acute and chronic hepatobiliary manifestations of sickle cell disease: a review. World J Gastrointest Pathophysiol. 2017;8(3):108-16.

  49. Al-Jafar H, Alk-haldi JA, Termos S. Etiology based sickle cell disease hepatopathy. O J Gastroenterol. 2020;10:187-201. Disponible en: https://doi.org/10.4236/ojgas.2020.107019

  50. Goodwin EF, Partain PI, Lebensburger JD, Fineberg NS, Howard TH. Elective cholecystectomy reduces morbidity of cholelithiasis in pediatric sickle cell disease. Pediatr. Blood Cancer. 2017;64:113-20.

  51. Oguntoye OO, Ndububa DA, Yusuf M, Bolarinwa RA, Ayoola OO. Hepatobiliary ultrasonographic abnormalities in adult patients with sickle cell anaemia in steady state in Ile-Ife, Nigeria. Pol J Radiol. 2017;82:1-8. Disponible en: https://doi.org/10.12659/PJR.899609

  52. Pecker LH, Patel N, Creary N, Darbari A, Riehm Meier E, Darbari DS, Fasano RM. Diverse manifestations of acute sickle cell hepatopathy in pediatric patients with sickle cell disease: A case series. Pediatr. Blood Cancer. 2018;65:e270060.

  53. Issa H, Al-Haddad A, Al-Salem A. Sickle cell cholangiopathy: An endoscopic retrograde cholangiopancreatography evaluation. World J Gastroenterol. 2009;15:5316-20.

  54. Colli A, Berzuinin A, Prati D. Liver sequestration in sickle-cell disease and hepatitis. Lancet. 2018;392:e16.

  55. Allali S, de Montalembert M, Brousse V. Hepatobiliary complications in children with sickle cell disease: A retrospective review of medical records from 616 patients. Journal of Clinical Medicine. 2019;8:1481. Disponible en: https://doi.org/10.3390/jcm8091481

  56. Guimarães JA, Silva LCDS. Sickle cell intrahepatic cholestasis unresponsive to exchange blood transfusion: a case report. Revista Brasileira de Hematología e Hemoterapia. 2017;39:163-6. Disponible en: https://doi.org/10.1016/j.bjhh.2017.02.006

  57. Baddam S, Aban I, Hilliard L, Howard T, Askenazi D, Lebensburger JD. Acute kidney injury during a pediatric sickle cell vaso-occlusive pain crisis. Pediatr Nephrol. 2017;32(8):1451-56.

  58. Drawz P, Ayyappan S, Nouraie M, Saraf S, Gordeuk V, Hostetter T. Kidney disease among patients with sickle cell disease, hemoglobin ss and sc. Clin J Am Soc Nephrol. 2016;11:207-15. Disponible en: https://doi.org/10.2215/CJN.03940415

  59. Audard V, Bartolucci P, Stehle T. Sickle cell disease and albuminuria: recent advances in our understanding of sickle cell nephropathy. Clinical Kidney Journal. 2017;10(4):475-8. Disponible en: https://doi.org/10.1093/ckj/sfx027

  60. Haymann JP, Hammoudi N, Stankovic K, Galacteros F, Habibi A, Avellino V, et al. Renin-angiotensin system blockade promotes a cardio-renal protection in albuminuric homozygous sickle cell patients. B J Haematol. 2017;179:820-28. Disponible en: https://doi.org/10.1111/bjh.14969

  61. Boyle SM, Jacobs B, Sayani FA, Hoffman B. Management of the dialysis patient with sickle cell disease. Semin Dial. 2016;29(1):62-70.

  62. Nath KA, Hebbel RP. Sickle cell disease: renal manifestations and mechanisms. Nat Rev Nephrol. 2015;11(3):161-71. Disponible en: https://doi.org/10.1038/nrneph.2015.8

  63. Brandow AM, DeBaun MR. Key components of pain management for children and adults with sickle cell disease. Hematol Oncol Clin North Am. 2018;32(3):535-50. Disponible en: https://doi.org/10.1016/j.hoc.2018.01.014

  64. Case Mi, Zhang H, Mundahl J, Datta Y, Nelson S, Gupta K, et al. Characterization of functional brain activity and connectivity using EEG and fMRI in patients with sickle cell disease. NeuroImage Clinical. 2017;14:1-17. Disponible en: https://doi.org/10.1016/j.nicl.2016.12.024

  65. Chaturvedi S, Bhatnagar P, Bean CJ. Genome-wide association study to identify variants associated with acute severe vaso-occlusive pain in sickle cell anemia. Blood. 2017;130(5):686-8.

  66. Dampier C. New and emerging treatments for vaso-occlusive pain in sickle cell disease. Expert Rev Hematol. 2019;12(10):857-72. Disponible en: https://doi.org/10.1080/17474086.2019.1649131

  67. National Institute for Health and Care Excellence. Sickle Cell Acute Painful Episode Overview. 2015. Disponible en: https://www.nice.org.uk/Guidance/CG143

  68. Field JJ, Ballas SK, Campbell C, Crosby LE, Dampier C, Darbari‖ DS, et al. Analgesic, anesthetic, and addiction clinical trial translations, innovations, opportunities, and networks-american pain society-american academy of pain medicine, pain taxonomy, diagnostic criteria for acute sickle cell disease pain. Journal of Pain. 2019. Disponible en: https://doi.org/10.1016/j.jpain.2018.12.003

  69. Veluswamy S, Shah P, Denton C, Chalacheva P, Khoo M, Coates T. Vaso-occlusion in sickle cell disease: is autonomic dysregulation of the microvasculature the trigger? J Clinical Med. 2019;8(10):1690.

  70. Darbari DS, Sheehan VA, Ballas SK. The vaso-occlusive pain crisis in sickle cell disease: definition, pathophysiology, and management. Eur J Haematol; 2020.

  71. Palermo TM, Dudeney J, Santanelli JP. Feasibility and acceptability of internet-delivered cognitive behavioral therapy for chronic pain in adolescents with sickle cell disease and their parents. J Pediatr Hematol Oncol. 2018;40(2):122-7.

  72. El Hoss S, Cochet S, Marin M, Lapouméroulie C, Dussiot M, Bouazza N, et al. Insights into determinants of spleen injury in sickle cell anemia. Blood Adv. 2019;3(15):2328-36.

  73. Ben Khaled M, Ouederni M, Mankai Y, Rekaya S, Ben Fraj I, Dhouib N, et al. Prevalence and predictive factors of splenic sequestration crisis among 423 pediatric patients with sickle cell disease in Tunisia. Blood Cells Mol Dis. 2020;80:102374.

  74. Menaa F, Khan BA, Uzair B, Menaa A. Sickle cell retinopathy: improving care with a multidisciplinary approach. J Multidiscip Healthc. 2017;10:335-46.

  75. Alam M, Thapa D, Lim JI, Cao D, Yao X. Quantitative characteristics of sickle cell retinopathy in optical coherence tomography angiography. Biomedical Optics Express. 2017;8(3):1741-53. Disponible en: https://doi.org/10.1364/BOE.8.001741

  76. Alkhaibari MS. Retinal occlusion as an advanced complication of sickle cell disease. New Front Ophthalmol. 2016;2(6):1-7. Disponible en: https://doi.org/10.15761/NFO.1000147

  77. Weisman JK, Nickel RS, Darbari DS, Hanisch BR, Diab YA. Characteristics and outcomes of osteomyelitis in children with sickle cell disease: a 10-year single-center experience. Pediatric Blood & Cancer. 2020;67(5):e28225.

  78. Kosaraju V, Harwani A, Partovi S, Bhojwani N, Garg V, Ayyappan S, et al. Imaging of musculoskeletal manifestations in sickle cell disease patients. The B J Radiol. 2017;90(1073):20160130.

  79. Adesina OO, Neumayr LD. Osteonecrosis in sickle cell disease: an update on risk factors, diagnosis, and management. Hematology. American Society of Hematology. Education Program. 2019;1:351-58.

  80. Vanderhave KL, Perkins CA, Scannell B, Brighton BK. Orthopaedic manifestations of sickle cell disease. J Am Acad Orthop Surg. 2018;26:94-101. Disponible en: https://doi.org/10.5435/JAAOS-D-16-00255

  81. Minniti CP, Kato GJ. How we treat sickle cell patients with leg ulcers. Am J Hematol. 2016;91:22-30. Disponible en: https://doi.org/10.1002/ajh.24134

  82. Senet P, Blas-Chatelain C, Levy P, Manea EM, Peschanski M, Mirault T, et al. Factors predictive of leg-ulcer healing in sickle cell disease: a multicentre, prospective cohort study. B J Dermatol. 2017;177(1):206-11.

  83. Chinegwundoh FI, Smith S, Anie KA. Treatments for priapism in boys and men with sickle cell disease. Cochrane Database of Systematic Reviews. 2017;9:CD004198. Disponible en: http//doi.org/10.1002/14651858.CD004198.pub3

  84. Akinbami A, Uche E, Dosunmu A. Priapism in sickle-cell disease: Emergency room intervention. Ann Trop Pathol. 2017;8:5-10. Disponible en: https://doi.org/10.4103/atp.atp_17_17

  85. Platt OS, Rosenstock W, Espeland MA. Influence of sickle hemoglobinopathies on growth and development. N Engl J Med. 1984;311:7-12.

  86. Botelho EC, Mataratzis PSR, Lino L, de Oliveira AN, Bezerra FF, dos Santos Barbosa Brito F, et al. Nutritional status, nutrient intake, and food diversity among children with sickle cell anemia. Journal of Pediatric Hematology/Oncology. 2019;41(3):e141-5. Disponible en: https://doi.org/10.1097/MPH.0000000000001377

  87. Chou S, Fasano R. Management of patients with sickle cell disease using transfusion therapy. Hematol Oncol Clin North Am. 2016;30:591-608.

  88. Hibbert JM, Creary MS, Gee BE, Buchanan I, Quarshie A, Hsu LL. Erythropoiesis and myocardial energy requirements contribute to the hypermetabolism of childhood sickle cell anemia. J Pediatr Gastroenterol Nutr. 2006;43:680-7. Disponible en: http//doi.org/10.1097/01.mpg.0000228120.44606.d6

  89. de Montalembert M, Ribeil JA, Brousse V. Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome. PLoS One. 2017;12:e0172147.

  90. McDowell LA, Sticco KL. Iron Overload. Stat Pearls Publishing, Treasure Island. 2020. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK526131

  91. Yassin M, Soliman A, De Sanctis V, Nashwan A, Abusamaan S, Moustafa A, et al. Liver iron content (LIC) in adults with sickle cell disease (SCD): correlation with serum ferritin and liver enzymes concentrations in trasfusion dependent (TD-SCD) and non-transfusion dependent (NT-SCD) patients. Mediterr J Hematol Infect Dis. 2017,9(1):e2017037. Disponible en: https://doi.org/10.4084/MJHID.2017.037

  92. Sippert EA, Laguila JE, Alves HV, Rodrigues C, Olenscki SC, Addas-Carvalho M, et al. Red blood cell alloimmunization in patients with sickle cell disease: correlation with HLA and cytokine gene polymorphisms. Transfusion. 2017;57;379-89.

  93. Howard J. Sickle cell disease: when and how to transfuse. Hematology Am Soc Hematol Educ Program. 2016:625-31.

  94. Banks M MD, Shikle J. Hyperhemolysis syndrome in patients with sickle cell disease. Arch Pathol Lab Med. 2018;142:1425-27. Disponible en: https:doi.org/10.5858/arpa.2017-0251-RS




2020     |     www.medigraphic.com